CAREDX, INC. (CDNA) Free cash flow
- Free cash flow · 12 months (USD): Value (m); Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | (m) | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | (m) | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $93.66M | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | 0.84× | Operating cash flow / net income. Period ending 2026-06-30. $93.66M ÷ $111.01M ≈ 0.84× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | 93.66M USD | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations |
| Capital spending | (m) | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | (m) | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations · Payments to Acquire Property, Plant, and Equipment |
| Revenue | 458.09M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | 111.01M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $93.66M | (m) | (m) | $458.09M | (m) | $111.01M | (m) | (m) | (m) | 0.84× |
| 2026-03-31 | (m) | (m) | $72.95M | (m) | (m) | $412.82M | (m) | $-8.19M | (m) | (m) | (m) | -8.90× |
| 2025-12-31 | (m) | (m) | $42.03M | (m) | (m) | $379.81M | (m) | $-21.35M | (m) | (m) | (m) | -1.97× |
| 2025-09-30 | (m) | (m) | $42.56M | (m) | (m) | $358.00M | (m) | $70.45M | (m) | (m) | (m) | 0.60× |
| 2025-06-30 | (m) | (m) | $17.72M | (m) | (m) | $340.83M | (m) | $58.14M | (m) | (m) | (m) | 0.30× |
| 2025-03-31 | (m) | (m) | $26.78M | (m) | (m) | $346.42M | (m) | $62.08M | (m) | (m) | (m) | 0.43× |
| 2024-12-31 | (m) | (m) | $38.05M | (m) | (m) | $333.79M | (m) | $52.55M | (m) | (m) | (m) | 0.72× |
| 2024-09-30 | (m) | (m) | $7.78M | (m) | (m) | $312.77M | (m) | $-143.56M | (m) | (m) | (m) | -0.05× |
| 2024-06-30 | (m) | (m) | $-14.92M | (m) | (m) | $297.08M | (m) | $-159.63M | (m) | (m) | (m) | 0.09× |
| 2024-03-31 | (m) | (m) | $-34.37M | (m) | (m) | $275.11M | (m) | $-183.19M | (m) | (m) | (m) | 0.19× |
| 2023-12-31 | (m) | (m) | $-18.39M | (m) | (m) | $280.32M | (m) | $-190.28M | (m) | (m) | (m) | 0.10× |
| 2023-09-30 | (m) | (m) | $-2.82M | (m) | (m) | $297.14M | (m) | $-90.52M | (m) | (m) | (m) | 0.03× |
| 2023-06-30 | (m) | (m) | $278.00K | (m) | (m) | $309.31M | (m) | $-83.97M | (m) | (m) | (m) | -0.00× |
| 2023-03-31 | (m) | (m) | $-3.10M | (m) | (m) | $319.64M | (m) | $-80.71M | (m) | (m) | (m) | 0.04× |
| 2022-12-31 | (m) | (m) | $-25.24M | (m) | (m) | $321.79M | (m) | $-76.61M | (m) | (m) | (m) | 0.33× |
| 2022-09-30 | (m) | (m) | $-28.26M | (m) | (m) | $318.63M | (m) | $-74.44M | (m) | (m) | (m) | 0.38× |
| 2022-06-30 | (m) | (m) | $-20.80M | (m) | (m) | $314.86M | (m) | $-69.39M | (m) | (m) | (m) | 0.30× |
| 2022-03-31 | (m) | (m) | $-7.13M | (m) | (m) | $308.41M | (m) | $-49.62M | (m) | (m) | (m) | 0.14× |
| 2021-12-31 | (m) | (m) | $-19.29M | (m) | (m) | $296.40M | (m) | $-30.66M | (m) | (m) | (m) | 0.63× |
| 2021-09-30 | (m) | (m) | $-16.28M | (m) | (m) | $275.82M | (m) | $-18.03M | (m) | (m) | (m) | 0.90× |
| 2021-06-30 | (m) | (m) | $-11.45M | (m) | (m) | $253.60M | (m) | $-8.95M | (m) | (m) | (m) | 1.28× |
| 2021-03-31 | (m) | (m) | $2.86M | (m) | (m) | $221.21M | (m) | $-13.58M | (m) | (m) | (m) | -0.21× |
| 2020-12-31 | (m) | (m) | $33.43M | (m) | (m) | $192.19M | (m) | $-18.71M | (m) | (m) | (m) | -1.79× |
| 2020-09-30 | (m) | (m) | $25.17M | (m) | (m) | $169.37M | (m) | $-19.98M | (m) | (m) | (m) | -1.26× |
| 2020-06-30 | (m) | (m) | $20.57M | (m) | (m) | $149.81M | (m) | $-18.97M | (m) | (m) | (m) | -1.08× |
| 2020-03-31 | (m) | (m) | $43.00K | (m) | (m) | $139.47M | (m) | $-20.26M | (m) | (m) | (m) | -0.00× |
| 2019-12-31 | (m) | (m) | $-2.77M | (m) | (m) | $127.07M | (m) | $-21.97M | (m) | (m) | (m) | 0.13× |
| 2019-09-30 | $-1.62M | (m) | $312.00K | $1.93M | (m) | $114.76M | (m) | $-20.95M | (m) | (m) | -1.41% | -0.01× |
| 2019-06-30 | $-2.03M | (m) | $106.00K | $2.13M | (m) | $102.13M | (m) | $-39.10M | (m) | (m) | -1.99% | -0.00× |
| 2019-03-31 | $-7.87M | (m) | $-5.36M | $2.52M | (m) | $88.50M | (m) | $-45.32M | (m) | (m) | -8.90% | 0.12× |
| 2018-12-31 | $-6.04M | (m) | $-4.01M | $2.04M | (m) | $76.57M | (m) | $-46.76M | (m) | (m) | -7.89% | 0.09× |
| 2018-09-30 | $-9.32M | (m) | $-8.15M | $1.16M | (m) | $65.56M | (m) | $-74.67M | (m) | (m) | -14.21% | 0.11× |
| 2018-06-30 | $-11.33M | (m) | $-10.77M | $553.00K | (m) | $56.57M | (m) | $-68.97M | (m) | (m) | -20.02% | 0.16× |
| 2018-03-31 | $-12.26M | (m) | $-12.08M | $180.00K | (m) | $50.79M | (m) | $-58.88M | (m) | (m) | -24.15% | 0.21× |
| 2017-12-31 | $-14.49M | (m) | $-14.31M | $186.00K | (m) | $48.32M | (m) | $-55.47M | (m) | (m) | -29.99% | 0.26× |
| 2017-09-30 | $-15.24M | (m) | $-15.22M | $22.00K | (m) | $46.68M | (m) | $-39.28M | (m) | (m) | -32.65% | 0.39× |
| 2017-06-30 | $-14.57M | (m) | $-14.20M | $367.00K | (m) | $46.96M | (m) | $-28.78M | (m) | (m) | -31.02% | 0.49× |
| 2017-03-31 | $-17.58M | (m) | $-17.07M | $508.00K | (m) | $45.65M | (m) | $-35.28M | (m) | (m) | -38.51% | 0.48× |
| 2016-12-31 | $-17.07M | (m) | $-16.52M | $549.00K | (m) | $40.63M | (m) | $-39.47M | (m) | (m) | -42.02% | 0.42× |
| 2016-09-30 | $-18.14M | (m) | $-17.44M | $703.00K | (m) | $36.42M | (m) | $-28.75M | (m) | (m) | -49.81% | 0.61× |
| 2016-06-30 | $-20.01M | (m) | $-19.26M | $742.00K | (m) | $31.10M | (m) | $-28.47M | (m) | (m) | -64.33% | 0.68× |
| 2016-03-31 | $-15.87M | (m) | $-14.93M | $944.00K | (m) | $27.49M | (m) | $-21.19M | (m) | (m) | -57.74% | 0.70× |
| 2015-12-31 | $-10.95M | (m) | $-9.75M | $1.20M | (m) | $28.14M | (m) | $-13.71M | (m) | (m) | -38.91% | 0.71× |
| 2015-09-30 | $-8.02M | (m) | $-6.50M | $1.52M | (m) | $29.45M | (m) | $-8.95M | (m) | (m) | -27.24% | 0.73× |
| 2015-06-30 | $-8.43M | (m) | $-7.13M | $1.30M | (m) | $28.95M | (m) | $-4.25M | (m) | (m) | -29.13% | 1.68× |
| 2015-03-31 | $-5.62M | (m) | $-4.54M | $1.08M | (m) | $28.60M | (m) | $-187.00K | (m) | (m) | -19.66% | 24.30× |
| 2014-12-31 | $-4.08M | (m) | $-3.35M | $733.00K | (m) | $27.31M | (m) | $781.00K | (m) | (m) | -14.95% | -4.29× |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) | (m) | $23.04M | (m) | $-3.50M | (m) | (m) | (m) | (m) |
| 2013-12-31 | $-644.00K | (m) | $-546.00K | $98.00K | (m) | $22.10M | (m) | $-3.54M | (m) | (m) | -2.91% | 0.15× |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $-1.92M | (m) | $-1.78M | $141.00K | (m) | $20.45M | (m) | $-5.06M | (m) | (m) | -9.37% | 0.35× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |